Kinetics of infected cell appearance as a determinant of number of human immunodeficiency virus-1 infectious units.

PubWeight™: 0.80‹?›

🔗 View Article (PMID 2497763)

Published in AIDS Res Hum Retroviruses on February 01, 1989

Authors

J M Cory1, B M Ohlsson-Wilhelm, M E Steck, M D Smithgall, V Rozday, M E Eyster, F Rapp

Author Affiliations

1: Department of Microbiology and Immunology, Milton S. Hershey Medical Center, Pennsylvania State University, Hershey 17033.

Articles by these authors

(truncated to the top 100)

Properties of hamster embryo fibroblasts transformed in vitro after exposure to ultraviolet-irradiated herpes simplex virus type 2. J Virol (1971) 4.09

A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia. N Engl J Med (1989) 4.04

Oncogenic transformation of hamster cells after exposure to herpes simplex virus type 2. Nat New Biol (1971) 3.73

Malignant transformation of hamster embryo fibroblasts following exposure to ultraviolet-irradiated human cytomegalovirus. Virology (1973) 3.43

Three-year incidence of AIDS in five cohorts of HTLV-III-infected risk group members. Science (1986) 3.31

Three-year randomised study of high-purity or intermediate-purity factor VIII concentrates in symptom-free HIV-seropositive haemophiliacs: effects on immune status. Lancet (1993) 3.03

The effect of arabinofuranosylcytosine on the growth cycle of simian virus 40. Virology (1965) 2.98

Herpesviridae. Definition, provisional nomenclature, and taxonomy. The Herpesvirus Study Group, the International Committee on Taxonomy of Viruses. Intervirology (1981) 2.92

Association of 20-Millimicron Particles with Adenoviruses. J Bacteriol (1965) 2.76

Natural history of HIV-1 cell-free viremia. JAMA (1995) 2.58

Stimulation of cellular DNA synthesis by human cytomegalovirus. J Virol (1974) 2.54

Oncogenic transformation of hamster embryo cells after exposure to inactivated herpes simplex virus type 1. J Virol (1973) 2.44

Cytomegalovirus replication in cells pretreated with 5-iodo-2'-deoxyuridine. J Virol (1973) 2.41

Effects of pancreatin on the growth of reovirus. J Bacteriol (1966) 2.35

A randomized trial comparing fluconazole with clotrimazole troches for the prevention of fungal infections in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group. N Engl J Med (1995) 2.29

SV40-adenovirus "hybrid" populations: transfer of SV40 determinants from one type of adenovirus to another. Proc Natl Acad Sci U S A (1965) 2.27

Natural history of human immunodeficiency virus infections in hemophiliacs: effects of T-cell subsets, platelet counts, and age. Ann Intern Med (1987) 2.24

Trigeminal ganglion infection by thymidine kinase-negative mutants of herpes simplex virus. Science (1979) 2.23

Rescue of Epstein-Barr virus from somatic cell hybrids of Burkitt lymphoblastoid cells. J Virol (1972) 2.17

Cytomegalovirus: conversion of nonpermissive cells to a permissive state for virus replication. Science (1973) 2.15

The development by cytomegalovirus-infected cells of binding affinity for normal human immunoglobulin. J Immunol (1976) 2.12

A new overlay for plaquing animal viruses. Proc Soc Exp Biol Med (1968) 1.99

Propolypeptide of von Willebrand factor circulates in blood and is identical to von Willebrand antigen II. Science (1986) 1.91

Transformation of mammalian cells by DNA-containing viruses following photodynamic inactivation. Virology (1973) 1.85

Inhibition of adenovirus replication by 1-beta-D-arabinofuranosylcytosine. Proc Soc Exp Biol Med (1966) 1.83

Interaction of a simian papovavirus and adenoviruses. I. Induction of adenovirus tumor antigen during abortive infection of simian cells. J Bacteriol (1966) 1.79

Antigenic differences between isolates of herpesvirus type 2. Intervirology (1974) 1.79

Oncogenic transformation of human embryo lung cells by human cytomegalovirus. Science (1976) 1.76

Measles virus and its associated diseases. Bacteriol Rev (1977) 1.55

Activation of a latent measles virus infection in hamster cells. J Virol (1973) 1.54

Latency of human measles virus in hamster cells. J Virol (1972) 1.53

Detection of a virus-specific antigen on the surface of herpes simplex virus-transformed cells. J Virol (1975) 1.52

Transcription during bacteriophage SPO1 development: mutations affecting the program of viral transcription. J Mol Biol (1971) 1.52

Central nervous system bleeding in hemophiliacs. Blood (1978) 1.51

Development and early natural history of HTLV-III antibodies in persons with hemophilia. JAMA (1985) 1.50

Silent infections with human immunodeficiency virus type 1 are highly unlikely in multitransfused seronegative hemophiliacs. Blood (1990) 1.49

Long-term persistence of cytomegalovirus genome in cultured human cells of prostatic origin. J Virol (1975) 1.48

Differential effect of arabinofuranosylthymine of the replication of human herpesviruses. J Virol (1977) 1.44

Heterosexual transmission of human immunodeficiency virus: association with severe depletion of T-helper lymphocytes in men with hemophilia. AIDS Res Hum Retroviruses (1987) 1.44

Synthesis of Epstein-Barr virus antigens and DNA in activated Burkitt somatic cell hybrids. Virology (1973) 1.44

Diffusion and imaging properties of three new lipophilic tracers, NeuroVue Maroon, NeuroVue Red and NeuroVue Green and their use for double and triple labeling of neuronal profile. Brain Res Bull (2005) 1.44

Synthesis of virus deoxyribonucleic acid during abortive infection of simian cells by human adenoviruses. J Bacteriol (1966) 1.43

Studies of an Epstein-Barr virus-induced DNA polymerase. Virology (1977) 1.43

Latent measles virus infection of the hamster central nervous system. J Immunol (1971) 1.42

Quantitative characteristics of the transformation of hamster cells by PARA (defective simian virus 40)-adenovirus 7. J Virol (1970) 1.42

Cell-dependent differences in the production of infectious herpes simplex virus at a supraoptimal temperature. J Virol (1972) 1.41

Acid-labile alpha interferon. A possible preclinical marker for the acquired immunodeficiency syndrome in hemophilia. N Engl J Med (1983) 1.41

Increased liver decompensation risk with atypical hepatitis C virus antibody levels. J Infect Dis (2000) 1.41

Measles virus: an unwanted variant causing hydrocephalus. Science (1975) 1.40

Induction of cellular DNA synthesis and increased mitotic activity in syrian hamster embryo cells abortively infected with human cytomegalovirus. J Gen Virol (1976) 1.40

Herpes simplex virus DNA in transformed cells: sequence complexity in five hamster cell lines and one derived hamster tumor. J Virol (1976) 1.39

SV40-adenovirus "hybrids": presence of two genotypes and the requirement of their complementation for viral replication. Virology (1966) 1.37

Characterization of high-risk HIV-1 seronegative hemophiliacs. Clin Immunol (2001) 1.35

High efficiency latency and activation of herpes simplex virus in human cells. Science (1982) 1.34

Herpes simplex virus latency in cultured human cells following treatment with cytosine arabinoside. J Gen Virol (1972) 1.33

Analysis by restriction enzyme cleavage of human varicella-zoster virus DNAs. Virology (1977) 1.32

Analysis of the DNAs from seven varicella-zoster virus isolates. J Virol (1979) 1.31

Variation in properties of plaque progeny of PARA (defective simian papovavirus 40)-adenovirus 7. J Virol (1969) 1.28

Induction of host DNA synthesis and DNA polymerase by DNA-negative temperature-sensitive mutants of human cytomegalovirus. Virology (1979) 1.28

Risk of AIDS after herpes zoster. Lancet (1987) 1.28

Cryptosporidiosis in a patient with hemophilia, common variable hypogammaglobulinemia, and the acquired immunodeficiency syndrome. Ann Intern Med (1983) 1.24

Papovavirus SV40 transplantation immunity conferred by an adenovirus-SV40 hybrid. J Natl Cancer Inst (1966) 1.23

Isolation and preliminary characterization of temperature-sensitive mutants of measles virus. J Virol (1975) 1.22

Different effects of MgC1-2 and MgSO-4 on the thermostability of viruses. Virology (1965) 1.21

Antibodies reactive with human T cell leukemia viruses in the serum of hemophiliacs receiving factor VIII concentrate. Blood (1985) 1.21

Replication in simian cells of defective viruses in an SV40-adenovirus "hybrid" population. J Bacteriol (1966) 1.21

Variants of defective simian papovavirus 40 (PARA) characterized by cytoplasmic localization of simian papovavirus 40 tumor antigen. J Virol (1969) 1.21

Comparison of the DNAs of varicella-zoster viruses isolated from clinical cases of varicella and herpes zoster. Virology (1977) 1.21

Experimental measles encephalitis: a genetic analysis. Infect Immun (1975) 1.21

Intracellular branched tubular structures in osteosarcoma. An ultrastructural and serological study. Cancer (1971) 1.20

Septicemia due to Capnocytophaga (Bacteroides ocharaceus) in Hodgkin's disease. Ann Intern Med (1979) 1.19

Role of interferon in replication of virulent and attenuated strains of measles virus. J Gen Virol (1969) 1.19

Production of mucopolysaccharides by normal and transformed cells. Proc Natl Acad Sci U S A (1973) 1.19

Involvement of an early human cytomegalovirus function in reactivation of quiescent herpes simplex virus type 2. J Virol (1981) 1.18

Herpes simplex virus latency in isolated human neurons. Proc Natl Acad Sci U S A (1984) 1.18

Influence of SV40 Genome on the Replication of an Adenovirus-SV40 "Hybrid" Population. J Bacteriol (1965) 1.17

Isolation of herpes simplex virus DNA from the "hirt supernatant". Virology (1976) 1.15

Analysis of the herpes simplex virus genome during in vitro latency in human diploid fibroblasts and rat sensory neurons. J Virol (1984) 1.15

Complementation between a defective monkey cell-adapting component and human adenoviruses in simian cells. Virology (1967) 1.14

Thymidine kinase activity in Burkitt lymphoblastoid somatic cell hybrids after induction of the EB virus. Proc Soc Exp Biol Med (1973) 1.14

Papovavirus SV40, adenovirus and their hybrids: transformation, complementation, and transcapsidation. Prog Med Virol (1966) 1.14

Loss of high-responder inhibitors in patients with severe hemophilia A and human immunodeficiency virus type 1 infection: a report from the Multi-Center Hemophilia Cohort Study. Am J Hematol (1993) 1.14

Identification of the herpes simplex virus DNA sequences present in six herpes simplex virus thymidine kinase-transformed mouse cell lines. J Virol (1980) 1.13

Identification of the molecular defect in the erythrocyte membrane skeleton of some kindreds with hereditary spherocytosis. Blood (1982) 1.13

Reaction of serum from pregnant hamsters with surface of cells transformed by SV40. J Immunol (1970) 1.12

A novel approach to study the DNA of herpes zoster virus. Intervirology (1977) 1.11

Repression and activation of the genome of herpes simplex viruses in human cells. Proc Natl Acad Sci U S A (1981) 1.09

Question: do herpesviruses cause cancer? Answer: of course they do. J Natl Cancer Inst (1973) 1.09

Lack of relationship between virus-specific surface and transplantation antigens in hamster cells transformed by simian papovavirus SV40. J Immunol (1968) 1.09

Cytomegalovirus and cancer of the prostate: in vitro transformation of human cells. Cancer Treat Rep (1977) 1.08

Topology and order of formation of interchain disulfide bonds in von Willebrand factor. Blood (1987) 1.08

Deoxythymidine kinase from rabbit kidney cells infected with herpes simplex virus types 1 and 2. Intervirology (1973) 1.08

Varicella-zoster virus-induced DNA polymerase. J Gen Virol (1977) 1.07

Inducers of erythroid differentiation in K562 human leukemia cells. Exp Hematol (1981) 1.07

Differences in thermal stability of deoxythymidine kinase activity in extracts from cell infected with herpes simplex virus type 1 or type 2. Virology (1971) 1.07

Demonstration of oncogenic potential of mammalian cells transformed by DNA-containing viruses following photodynamic inactivation. Int J Cancer (1975) 1.06

Erythroid colony formation from human fetal liver. Proc Natl Acad Sci U S A (1978) 1.06

In vitro cell transformation by herpesviruses. Fed Proc (1973) 1.06

Phenotypic expressions of CCR5-delta32/delta32 homozygosity. J Acquir Immune Defic Syndr (1999) 1.05

Comparison of the polypeptides of several strains of human cytomegalovirus. J Gen Virol (1977) 1.05